Kintara Therapeutics Says On May 30 CFO Scott Praill Resigned
Portfolio Pulse from Benzinga Newsdesk
Kintara Therapeutics announced that CFO Scott Praill resigned on May 30.
June 02, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kintara Therapeutics' CFO Scott Praill resigned on May 30, potentially impacting the company's stock price.
CFO Scott Praill's resignation from Kintara Therapeutics may lead to uncertainty among investors and could negatively impact the stock price in the short term. The importance of this news is relatively high as the CFO plays a crucial role in the company's financial management.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100